Source | Evidence on protein | Close homologs |
---|---|---|
Cuervo et al. | no | yes: 0 |
Hassani et al. | no | yes: 0 |
Forrest at al. (metacyclic) | no | yes: 0 |
Forrest at al. (procyclic) | no | yes: 0 |
Silverman et al. | no | yes: 0 |
Pissara et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Pires et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Silverman et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Jamdhade et al. | no | yes: 18 |
Source | Evidence on protein | Close homologs |
---|---|---|
DeepLoc | ||
SignalP6 | no | yes: 0, no: 11 |
NetGPI | no | yes: 0, no: 11 |
Term | Name | Level | Count |
---|---|---|---|
GO:0005840 | ribosome | 5 | 5 |
GO:0032991 | protein-containing complex | 1 | 5 |
GO:0043226 | organelle | 2 | 5 |
GO:0043228 | non-membrane-bounded organelle | 3 | 5 |
GO:0043229 | intracellular organelle | 3 | 5 |
GO:0043232 | intracellular non-membrane-bounded organelle | 4 | 5 |
GO:0110165 | cellular anatomical entity | 1 | 5 |
GO:1990904 | ribonucleoprotein complex | 2 | 5 |
Term | Name | Level | Count |
---|---|---|---|
GO:0006412 | translation | 4 | 5 |
GO:0006518 | peptide metabolic process | 4 | 5 |
GO:0006807 | nitrogen compound metabolic process | 2 | 5 |
GO:0008152 | metabolic process | 1 | 5 |
GO:0009058 | biosynthetic process | 2 | 5 |
GO:0009059 | macromolecule biosynthetic process | 4 | 5 |
GO:0009987 | cellular process | 1 | 5 |
GO:0019538 | protein metabolic process | 3 | 5 |
GO:0034641 | cellular nitrogen compound metabolic process | 3 | 5 |
GO:0034645 | obsolete cellular macromolecule biosynthetic process | 4 | 5 |
GO:0043043 | peptide biosynthetic process | 5 | 5 |
GO:0043170 | macromolecule metabolic process | 3 | 5 |
GO:0043603 | amide metabolic process | 3 | 5 |
GO:0043604 | amide biosynthetic process | 4 | 5 |
GO:0044237 | cellular metabolic process | 2 | 5 |
GO:0044238 | primary metabolic process | 2 | 5 |
GO:0044249 | cellular biosynthetic process | 3 | 5 |
GO:0044260 | obsolete cellular macromolecule metabolic process | 3 | 5 |
GO:0044271 | cellular nitrogen compound biosynthetic process | 4 | 5 |
GO:0071704 | organic substance metabolic process | 2 | 5 |
GO:1901564 | organonitrogen compound metabolic process | 3 | 5 |
GO:1901566 | organonitrogen compound biosynthetic process | 4 | 5 |
GO:1901576 | organic substance biosynthetic process | 3 | 5 |
Term | Name | Level | Count |
---|---|---|---|
GO:0003735 | structural constituent of ribosome | 2 | 5 |
GO:0005198 | structural molecule activity | 1 | 5 |
Leishmania | From | To | Domain/Motif | Score |
---|---|---|---|---|
CLV_C14_Caspase3-7 | 170 | 174 | PF00656 | 0.378 |
CLV_NRD_NRD_1 | 144 | 146 | PF00675 | 0.384 |
CLV_NRD_NRD_1 | 186 | 188 | PF00675 | 0.358 |
CLV_NRD_NRD_1 | 329 | 331 | PF00675 | 0.413 |
CLV_NRD_NRD_1 | 345 | 347 | PF00675 | 0.376 |
CLV_NRD_NRD_1 | 72 | 74 | PF00675 | 0.508 |
CLV_PCSK_KEX2_1 | 144 | 146 | PF00082 | 0.384 |
CLV_PCSK_KEX2_1 | 328 | 330 | PF00082 | 0.411 |
CLV_PCSK_KEX2_1 | 345 | 347 | PF00082 | 0.412 |
CLV_PCSK_PC1ET2_1 | 345 | 347 | PF00082 | 0.426 |
CLV_PCSK_SKI1_1 | 101 | 105 | PF00082 | 0.409 |
CLV_PCSK_SKI1_1 | 131 | 135 | PF00082 | 0.346 |
CLV_PCSK_SKI1_1 | 153 | 157 | PF00082 | 0.363 |
CLV_PCSK_SKI1_1 | 224 | 228 | PF00082 | 0.424 |
CLV_PCSK_SKI1_1 | 347 | 351 | PF00082 | 0.455 |
DOC_CYCLIN_yCln2_LP_2 | 244 | 250 | PF00134 | 0.494 |
DOC_MAPK_gen_1 | 144 | 156 | PF00069 | 0.362 |
DOC_MAPK_gen_1 | 319 | 326 | PF00069 | 0.373 |
DOC_MAPK_MEF2A_6 | 149 | 156 | PF00069 | 0.371 |
DOC_MAPK_MEF2A_6 | 195 | 202 | PF00069 | 0.440 |
DOC_PP1_RVXF_1 | 151 | 157 | PF00149 | 0.366 |
DOC_PP1_RVXF_1 | 268 | 274 | PF00149 | 0.411 |
DOC_USP7_MATH_1 | 286 | 290 | PF00917 | 0.371 |
DOC_USP7_UBL2_3 | 343 | 347 | PF12436 | 0.498 |
DOC_WW_Pin1_4 | 91 | 96 | PF00397 | 0.515 |
LIG_14-3-3_CanoR_1 | 101 | 110 | PF00244 | 0.409 |
LIG_14-3-3_CanoR_1 | 126 | 133 | PF00244 | 0.361 |
LIG_Actin_WH2_2 | 303 | 321 | PF00022 | 0.384 |
LIG_APCC_ABBA_1 | 263 | 268 | PF00400 | 0.320 |
LIG_BIR_III_4 | 106 | 110 | PF00653 | 0.467 |
LIG_BRCT_BRCA1_1 | 248 | 252 | PF00533 | 0.470 |
LIG_Clathr_ClatBox_1 | 263 | 267 | PF01394 | 0.332 |
LIG_Clathr_ClatBox_1 | 323 | 327 | PF01394 | 0.373 |
LIG_eIF4E_1 | 225 | 231 | PF01652 | 0.326 |
LIG_eIF4E_1 | 75 | 81 | PF01652 | 0.359 |
LIG_FHA_1 | 116 | 122 | PF00498 | 0.373 |
LIG_FHA_1 | 226 | 232 | PF00498 | 0.349 |
LIG_FHA_1 | 306 | 312 | PF00498 | 0.423 |
LIG_FHA_1 | 80 | 86 | PF00498 | 0.458 |
LIG_FXI_DFP_1 | 273 | 277 | PF00024 | 0.351 |
LIG_GBD_Chelix_1 | 303 | 311 | PF00786 | 0.314 |
LIG_LIR_Gen_1 | 157 | 167 | PF02991 | 0.436 |
LIG_LIR_Gen_1 | 172 | 182 | PF02991 | 0.280 |
LIG_LIR_Gen_1 | 32 | 42 | PF02991 | 0.346 |
LIG_LIR_Gen_1 | 47 | 56 | PF02991 | 0.370 |
LIG_LIR_Nem_3 | 172 | 178 | PF02991 | 0.364 |
LIG_LIR_Nem_3 | 272 | 276 | PF02991 | 0.352 |
LIG_LIR_Nem_3 | 32 | 37 | PF02991 | 0.340 |
LIG_LIR_Nem_3 | 47 | 53 | PF02991 | 0.360 |
LIG_MAD2 | 83 | 91 | PF02301 | 0.460 |
LIG_NRP_CendR_1 | 350 | 351 | PF00754 | 0.470 |
LIG_PCNA_yPIPBox_3 | 73 | 85 | PF02747 | 0.496 |
LIG_SH2_CRK | 179 | 183 | PF00017 | 0.342 |
LIG_SH2_GRB2like | 117 | 120 | PF00017 | 0.376 |
LIG_SH2_NCK_1 | 50 | 54 | PF00017 | 0.373 |
LIG_SH2_SRC | 6 | 9 | PF00017 | 0.405 |
LIG_SH2_STAP1 | 117 | 121 | PF00017 | 0.376 |
LIG_SH2_STAP1 | 175 | 179 | PF00017 | 0.351 |
LIG_SH2_STAP1 | 75 | 79 | PF00017 | 0.361 |
LIG_SH2_STAT3 | 75 | 78 | PF00017 | 0.375 |
LIG_SH2_STAT5 | 117 | 120 | PF00017 | 0.376 |
LIG_SH2_STAT5 | 179 | 182 | PF00017 | 0.321 |
LIG_SH2_STAT5 | 42 | 45 | PF00017 | 0.380 |
LIG_SH2_STAT5 | 6 | 9 | PF00017 | 0.451 |
LIG_SH3_3 | 259 | 265 | PF00018 | 0.354 |
LIG_SUMO_SIM_anti_2 | 240 | 245 | PF11976 | 0.460 |
LIG_SUMO_SIM_par_1 | 322 | 327 | PF11976 | 0.375 |
LIG_UBA3_1 | 68 | 74 | PF00899 | 0.523 |
LIG_WRC_WIRS_1 | 287 | 292 | PF05994 | 0.353 |
MOD_CDC14_SPxK_1 | 94 | 97 | PF00782 | 0.504 |
MOD_CDK_SPxK_1 | 91 | 97 | PF00069 | 0.504 |
MOD_CK1_1 | 163 | 169 | PF00069 | 0.403 |
MOD_CK1_1 | 171 | 177 | PF00069 | 0.368 |
MOD_CK1_1 | 23 | 29 | PF00069 | 0.582 |
MOD_CK2_1 | 26 | 32 | PF00069 | 0.371 |
MOD_Cter_Amidation | 340 | 343 | PF01082 | 0.412 |
MOD_GlcNHglycan | 37 | 40 | PF01048 | 0.414 |
MOD_GlcNHglycan | 65 | 68 | PF01048 | 0.464 |
MOD_GSK3_1 | 169 | 176 | PF00069 | 0.382 |
MOD_GSK3_1 | 93 | 100 | PF00069 | 0.474 |
MOD_N-GLC_1 | 237 | 242 | PF02516 | 0.420 |
MOD_NEK2_1 | 127 | 132 | PF00069 | 0.361 |
MOD_NEK2_1 | 140 | 145 | PF00069 | 0.367 |
MOD_NEK2_1 | 35 | 40 | PF00069 | 0.453 |
MOD_NEK2_1 | 99 | 104 | PF00069 | 0.424 |
MOD_PK_1 | 246 | 252 | PF00069 | 0.485 |
MOD_PKA_2 | 125 | 131 | PF00069 | 0.363 |
MOD_PKA_2 | 35 | 41 | PF00069 | 0.351 |
MOD_Plk_1 | 253 | 259 | PF00069 | 0.436 |
MOD_Plk_4 | 177 | 183 | PF00069 | 0.333 |
MOD_Plk_4 | 239 | 245 | PF00069 | 0.418 |
MOD_Plk_4 | 253 | 259 | PF00069 | 0.348 |
MOD_ProDKin_1 | 91 | 97 | PF00069 | 0.512 |
MOD_SUMO_for_1 | 133 | 136 | PF00179 | 0.348 |
MOD_SUMO_rev_2 | 249 | 256 | PF00179 | 0.400 |
MOD_SUMO_rev_2 | 267 | 271 | PF00179 | 0.301 |
MOD_SUMO_rev_2 | 277 | 287 | PF00179 | 0.423 |
TRG_DiLeu_BaEn_1 | 157 | 162 | PF01217 | 0.364 |
TRG_DiLeu_BaEn_1 | 76 | 81 | PF01217 | 0.337 |
TRG_ENDOCYTIC_2 | 117 | 120 | PF00928 | 0.376 |
TRG_ENDOCYTIC_2 | 159 | 162 | PF00928 | 0.369 |
TRG_ENDOCYTIC_2 | 175 | 178 | PF00928 | 0.340 |
TRG_ENDOCYTIC_2 | 179 | 182 | PF00928 | 0.200 |
TRG_ENDOCYTIC_2 | 50 | 53 | PF00928 | 0.363 |
TRG_ER_diArg_1 | 328 | 330 | PF00400 | 0.425 |
TRG_NLS_Bipartite_1 | 328 | 349 | PF00514 | 0.416 |
TRG_NLS_MonoExtC_3 | 341 | 346 | PF00514 | 0.400 |
TRG_NLS_MonoExtN_4 | 342 | 349 | PF00514 | 0.420 |
Protein | Taxonomy | Sequence identity | Coverage |
---|---|---|---|
A0A0N1HRD2 | Leptomonas seymouri | 92% | 80% |
A0A0S4IXC2 | Bodo saltans | 74% | 86% |
A0A1X0NX23 | Trypanosomatidae | 80% | 79% |
A0A3Q8IBU6 | Leishmania donovani | 99% | 100% |
A0A422N7Q3 | Trypanosoma rangeli | 78% | 78% |
A4HCY8 | Leishmania braziliensis | 96% | 80% |
A4I0H3 | Leishmania infantum | 99% | 100% |
C9ZV98 | Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) | 81% | 79% |
E9AWD5 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 98% | 100% |
V5AZ95 | Trypanosoma cruzi | 78% | 79% |